Therefore, similar to glucocorticoid treatments, NINJ1-targeted therapies may need to be combined with causal treatments (e.g., antibiotics for infections) to ensure that inflammation is controlled while also addressing the underlying causes of excessive cell death. Here, NINJ1 is linked to infection.